takeaway call
relev fwd-look data point call china began recov
march order pre-pandem level
tough play offens invest market sale forc new virtual tools/
remot monitor better posit recoveri competit dynam eas
post-crisi strong balanc sheet net cash emerg best
posit side
recap quit bad model rev y/
vs invisalign volum grew led america ou flat
reflect weak china apac volum declin though emea fare
better estimate headwind impact volum case
rev includ impact march offic close
across us/eu given track at/abov initi guidanc thru jan/feb estimate
case volum fell y/i march
china start recov possibl roadmap us/eu pull
guidanc offer littl direct commentari note china began improv earli
march order week lag b/w order case shipment current run
mid-jan level lockdown market like taiwan korea
also improv trail china perfect china data point best
signal term frame possibl roadmap us/eu said
note recoveri china uneven area guangdong shanghai
zhejiang at/abov pre-pandem level other beij hubei reopen later
 slower recov america may recov similar manner coastal
region ny ca like lag emea begin open particularli germani
heel toe despit substanti nt revenu headwind focus
offens prepar recoveri includ furlough salari cut sustain
marketing/media plan stay front-of-mind w/ consum invest select
ou market hire new rep china also support doc extend
payment term acceler launch new digit tool in-develop
invisalign virtual appoint virtual enabl remot consult progress
track new socially-distanc realiti
model chang cut ep rais ep
forecast case volum y/i assum declin
apr may forecast case volum follow
recoveri said visibl low expect teen case
start season summer like hold ok slope recoveri adult aesthet
case volum wildcard revis pt reflect recent peer group re-
rate impli ev/ebitda ev/rev slight discount high-
growth care comp ev/ebitda rev due somewhat higher exposur
elect procedures/discretionari spend environ
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
revenu flat flat invisalign case
nopat compound-annual-growth-rate next decad
price target impli ev ebitda
improv better mix lower coronaviru
impact operations/demand
faster adopt mandibular advanc
invisalign go north america
growth year target annual growth
stepped-up promo activ advers mix shift
advers coronaviru impact china biz
expect achiev sustain organ
revenu growth improv profit owe
product innov pipelin greenfield intenational market
new competit entrant recent emerg
algn moat wider perceiv view
invisalign penetr new greenfield intenational market
uptak mandibular advanc us
addit traction i-tero larg dso
pleas see import disclosur inform page report
pleas see import disclosur inform page report
inc histor project statement incomedollar million except per share amountshistor net product expens loss share share analysisgross research sale oper incom net growth analysisnet research sale oper net dilut jefferi co equiti research
pleas see import disclosur inform page report
inc histor project summari valuat analysisdollar million except per share amountshistor earn per flow cash cash flow ev cash flow per cash net interest free cash stock sheet metricsreceiv day day day convers debt ttm debt ttm valu per cash per align technolog jefferi co estim equiti research
design manufactur market invisalign system proprietari solut use treat malocclus
misalign teeth invisalign use seri clear remov retainer-lik applianc align gentli move teeth
pt impli ev ebitda price-to-earnings ex-cash discount high-growth care comp despit
brandon couillard certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
matthew stanton certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
peter apockoto certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
